Average Co-Inventor Count = 9.33
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astex Therapeutics Limited (28 from 123 patents)
2. Cancer Research Technology Limited (7 from 262 patents)
3. Otsuka Pharmaceutical Company, Limited (6 from 845 patents)
4. Novartis Ag (3 from 3,923 patents)
5. Taiho Pharmaceutical Company Limited (3 from 318 patents)
6. Smithkline Beecham Corporation (2 from 2,198 patents)
7. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
36 patents:
1. 12458640 - Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors
2. 12202828 - Bicyclic heterocycle compounds and their uses in therapy
3. 12077526 - Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
4. 12071429 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
5. 12037345 - Heterobicyclic compounds for inhibiting the activity of SHP2
6. 11939321 - Benzolactam compounds as protein kinase inhibitors
7. 11866428 - Bicyclic heterocycle compounds and their uses in therapy
8. 11643410 - Bicyclic heterocycle compounds and their uses in therapy
9. 11603367 - Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
10. 11466016 - Pharmaceutical compounds
11. 11261171 - Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
12. 11225476 - Bicyclic heterocycle compounds and their uses in therapy
13. 11001575 - Benzolactam compounds as protein kinase inhibitors
14. 10981898 - Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
15. 10618895 - Bicyclic heterocycle compounds and their uses in therapy